Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st

ACCESSWIRE
14 Apr 2021, 21:43 GMT+10

NAPLES, FL / ACCESSWIRE / April 14, 2021 / Enveric Biosciences (NASDAQ:ENVB) ('Enveric' or the 'Company'), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will present at the Planet MicroCap Showcase to be held virtually on Wednesday, April 21, 2021 at 9:00 a.m. ET. To access the live presentation, please register here.

For more information regarding the conference, or to schedule a one-on-one meeting with Enveric's management team, please contact KCSA Strategic Communications at EnvericBio@kcsa.com or register for the virtual event here.

If you can't make the live presentation, all company presentations 'webcasts' will be available directly on the conference event platform on this link under the tab 'Agenda': https://planetmicrocapshowcase.com/agenda

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN.Network.

If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

About Enveric Biosciences

Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. For more information, please visit https://www.enveric.com/.

Investor Contacts

Valter Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
valter@kcsa.com / asoss@kcsa.com

Media Contacts

Caitlin Kasunich / Raquel Cona
KCSA Strategic Communications
212.896.1241 / 516.779.2630
ckasunich@kcsa.com / rcona@kcsa.com

SOURCE: Enveric Biosciences via SNN Network

View source version on accesswire.com:
https://www.accesswire.com/640222/Enveric-Biosciences-to-Participate-in-the-Planet-MicroCap-Showcase-on-April-21st

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Detroit Star.

More Information

46 ℉

Fair in Windsor

International

Section

Melia, Georgian opposition leader, free from jail with EU help

TBILISI, Georgia: Opposition leader Nika Melia was released from jail this week. Melia's jailing had been seen as a largely ...

New California drought means less water, greater chance of wildfires

SACRAMENTO, California: California has expanded a drought emergency to 41 of 58 counties covering 12 million residents, some 30 percent ...

Test with genetically modified mosquitoes seeks to reduce diseases

TALLAHASSEE, Florida - To reduce the spread of diseases, such as dengue, yellow fever and the Zika virus, genetically modified ...

Defective roof clips cause Ford to recall 661,000 Explorers

DETROIT, Michigan: Acting on the request of federal regulators in the United States, American automaker Ford Motor will recall 661,000 ...

U.S. oil pipeline shutdown could cause jump in prices

WASHINGTON D.C.: Supply disruptions caused by the shutdown at Colonial Pipeline---the country's top fuel pipeline network---could result in prices rising ...